Figure 2From: Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem®) for bioequivalence in a randomized, open-label, two-period studyLumefantrine: arithmetic mean ± SD concentration-time profiles. Mean plasma concentration-time profiles for comparison of (A) 80/480 mg tablet and four standard tablets (B) 60/360 mg tablet and three standard tablets.Back to article page